Transcatheter Edge-to-Edge Mitral Valve Repair With the MitraClip G4 System

JACC Cardiovasc Interv. 2020 Oct 26;13(20):2402-2414. doi: 10.1016/j.jcin.2020.06.053. Epub 2020 Sep 30.

Abstract

Objectives: The primary objective of this study was to evaluate the effectiveness of the MitraClip G4 in the reduction of mitral regurgitation (MR).

Background: The next-generation MitraClip G4 system was recently introduced for the treatment of MR in the United States.

Methods: The study included consecutive patients undergoing transcatheter mitral edge-to-edge repair for MR with the MitraClip G4. The key outcome was the proportion of patients with MR reduction to ≤2+ at 30 days.

Results: Fifty-nine patients (median age 77 years, 62.7% men) were treated with the MitraClip G4. Reduction of MR to ≤2+ was achieved in 57 patients (96.6%) during the procedure, 58 patients (98.3%) at discharge, and 57 patients (96.6%) by 30 days. The median number of MitraClips used per patient was 2 (interquartile range: 1 to 3). Wide clips (NTW/XTW) were used in 82.7% of patients. The XTW clip was used most frequently as the first clip in patients with degenerative MR (65.4%) and the NTW clip in those with secondary MR (72.7%). The independent grasping mechanism was used in 49.2% of patients.

Conclusions: Use of the MitraClip G4 system was associated with excellent reduction in MR to ≤2+ in 96.6% of patients at 30 days. The availability of multiple MitraClip G4 sizes, especially the wide clips, and the ability to independently grasp leaflets are the likely contributors to MR reduction.

Keywords: MitraClip G4; mitral regurgitation.

MeSH terms

  • Aged
  • Female
  • Heart Valve Prosthesis Implantation*
  • Humans
  • Male
  • Mitral Valve Insufficiency* / surgery
  • Mitral Valve* / surgery
  • Treatment Outcome